• Drugmakers face government suits on generic price-fixing, too
• Some are already so indebted they can’t afford settlements

Debt holders are placing all-or-nothing bets on junk bonds from drug makers embroiled in lawsuits over the opioid epidemic and price-fixing.

The investors are taking advantage of sliding prices for notes issued by companies such as Endo International Plc, Mallinckrodt Plc and Teva Pharmaceutical Industries Ltd., which face allegations that they’ve fueled the opioid epidemic, and that they’ve engaged in price-fixing of generic drugs. Mallinckrodt is also in a legal battle with the U.S. over a plan to slash reimbursements on Acthar, the company’s star drug.

Continue reading at: https://www.bloomberg.com/news/articles/2019-05-23/this-may-hurt-a-little-or-a-lot-as-opioids-haunt-pharma-bonds